Universe Pharmaceuticals Growth Metrics (2021-2025) | UPC

Growth Metrics Sep2021 Sep2022 Mar2023 Sep2023 Mar2024 Sep2024 Sep2025
Growth Ratios
Assets Growth (1y) (Quarter) 243,521,825.10%-15.12%-1.40%-29.92%-29.75%162,762.16%1.99%
Assets Growth (3y) (Quarter) 11,214.74%889.48%951.92%
Assets Growth (5y) (Quarter) 7,420.72%
Cash & Equivalents Growth (1y) (Quarter) -19.69%70,604.67%-29.30%-7.46%55.15%458.11%-99.76%
Cash & Equivalents Growth (3y) (Quarter) 706.95%1,439.91%-76.92%
Cash & Equivalents Growth (5y) (Quarter) 47.50%
Enterprise Value Growth (1y) (Quarter) -116.77%-26,155.92%15.14%7.65%40.14%-484.03%99.77%
Enterprise Value Growth (3y) (Quarter) -707.02%-1,022.96%76.94%
Enterprise Value Growth (5y) (Quarter) -47.50%
Property, Plant & Equipment (Net) Growth (1y) (Quarter) -100.00%-9.20%-16.86%-12.96%-14.99%96,334.70%0.43%
Property, Plant & Equipment (Net) Growth (3y) (Quarter) -99.06%813.45%844.68%
Property, Plant & Equipment (Net) Growth (5y) (Quarter) -75.92%
Shareholder's Equity Growth (1y) (Quarter) 125.89%75,083.64%-22.94%-20.83%-43.25%62.68%23.35%
Shareholder's Equity Growth (3y) (Quarter) 1,003.72%889.32%16.68%
Shareholder's Equity Growth (5y) (Quarter) 385.53%
Total Debt Growth (1y) (Quarter) -100.00%17,033.62%74,528.34%62.24%39.50%145,713.96%-73.64%
Total Debt Growth (3y) (Quarter) -98.21%7,300.60%754.31%
Total Debt Growth (5y) (Quarter) -70.58%